177 related articles for article (PubMed ID: 11596086)
1. Ethnicity and cytokine production gauge response of patients with hepatitis C to interferon-alpha therapy.
Kimball P; Elswick RK; Shiffman M
J Med Virol; 2001 Nov; 65(3):510-6. PubMed ID: 11596086
[TBL] [Abstract][Full Text] [Related]
2. Comparison of 125I-interferon-alpha binding to peripheral blood cells from African-Americans and Caucasians with hepatitis C.
Kimball P; Verbeke S; Shiffman M
J Viral Hepat; 2003 Sep; 10(5):354-9. PubMed ID: 12969187
[TBL] [Abstract][Full Text] [Related]
3. mRNA cytokine profile in peripheral blood cells from chronic hepatitis C virus (HCV)-infected patients: effects of interferon-alpha (IFN-alpha) treatment.
Shapiro S; Gershtein V; Elias N; Zuckerman E; Salman N; Lahat N
Clin Exp Immunol; 1998 Oct; 114(1):55-60. PubMed ID: 9764603
[TBL] [Abstract][Full Text] [Related]
4. Viral dynamics and response differences in HCV-infected African American and white patients treated with IFN and ribavirin.
Layden-Almer JE; Ribeiro RM; Wiley T; Perelson AS; Layden TJ
Hepatology; 2003 Jun; 37(6):1343-50. PubMed ID: 12774013
[TBL] [Abstract][Full Text] [Related]
5. Contribution of genome-wide HCV genetic differences to outcome of interferon-based therapy in Caucasian American and African American patients.
Donlin MJ; Cannon NA; Aurora R; Li J; Wahed AS; Di Bisceglie AM; Tavis JE;
PLoS One; 2010 Feb; 5(2):e9032. PubMed ID: 20140258
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic response to peg-IFN-alpha-2b and ribavirin in HIV/HCV co-infected African-American and Caucasian patients as a function of HCV viral kinetics and interferon pharmacodynamics.
Rozenberg L; Haagmans BL; Neumann AU; Chen G; McLaughlin M; Levy-Drummer RS; Masur H; Dewar RL; Ferenci P; Silva M; Viola MS; Polis MA; Kottilil S
AIDS; 2009 Nov; 23(18):2439-50. PubMed ID: 19898214
[TBL] [Abstract][Full Text] [Related]
7. The influence of North American Aboriginal ethnicity on pro-inflammatory and anti-inflammatory cytokine responses to IFN-alpha.
Rempel JD; Aborsangaya KB; Alphonse MP; Minuk GY
J Viral Hepat; 2009 Apr; 16(4):292-7. PubMed ID: 19175873
[TBL] [Abstract][Full Text] [Related]
8. Increased baseline proinflammatory cytokine production in chronic hepatitis C patients with rapid virological response to peginterferon plus ribavirin.
Par G; Szereday L; Berki T; Palinkas L; Halasz M; Miseta A; Hegedus G; Szekeres-Bartho J; Vincze A; Hunyady B; Par A
PLoS One; 2013; 8(7):e67770. PubMed ID: 23874444
[TBL] [Abstract][Full Text] [Related]
9. Selection of genetic variants of the 5' noncoding region of hepatitis C virus occurs only in patients responding to interferon alpha therapy.
Lu M; Wiese M; Roggendorf M
J Med Virol; 1999 Oct; 59(2):146-53. PubMed ID: 10459148
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial of pegylated interferon alpha-2b plus ribavirin in the retreatment of chronic hepatitis C.
Jacobson IM; Gonzalez SA; Ahmed F; Lebovics E; Min AD; Bodenheimer HC; Esposito SP; Brown RS; Bräu N; Klion FM; Tobias H; Bini EJ; Brodsky N; Cerulli MA; Aytaman A; Gardner PW; Geders JM; Spivack JE; Rahmin MG; Berman DH; Ehrlich J; Russo MW; Chait M; Rovner D; Edlin BR
Am J Gastroenterol; 2005 Nov; 100(11):2453-62. PubMed ID: 16279900
[TBL] [Abstract][Full Text] [Related]
11. HCV viraemia associates with NK cell activation and dysfunction in antiretroviral therapy-treated HIV/HCV-co-infected subjects.
Papasavvas E; Azzoni L; Yin X; Liu Q; Joseph J; Mackiewicz A; Ross B; Lynn KM; Jacobson JM; Mounzer K; Kostman JR; Montaner LJ
J Viral Hepat; 2017 Oct; 24(10):865-876. PubMed ID: 28419653
[TBL] [Abstract][Full Text] [Related]
12. Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha.
Alvarado Esquivel C; Elewaut A; Philippé J; Elewaut AE; Desombere I; Maertens G; Leroux-Roels G
Rev Invest Clin; 2002; 54(1):41-50. PubMed ID: 11995406
[TBL] [Abstract][Full Text] [Related]
13. Selective decrease in hepatitis C virus-specific immunity among African Americans and outcome of antiviral therapy.
Rosen HR; Weston SJ; Im K; Yang H; Burton JR; Erlich H; Klarquist J; Belle SH;
Hepatology; 2007 Aug; 46(2):350-8. PubMed ID: 17659573
[TBL] [Abstract][Full Text] [Related]
14. Effect of cytokine gene polymorphism on histological activity index, viral load and response to treatment in patients with chronic hepatitis C genotype 3.
Abbas Z; Moatter T; Hussainy A; Jafri W
World J Gastroenterol; 2005 Nov; 11(42):6656-61. PubMed ID: 16425360
[TBL] [Abstract][Full Text] [Related]
15. Early changes in hepatitis C virus (HCV) RNA levels predict response to interferon treatment in noncirrhotic HCV patients.
Fallows G; Kaita K; Minuk G; Penner F; Smart G; Dawood M; Rosser B
Can J Gastroenterol; 2000; 14 Suppl B():30B-35B. PubMed ID: 10938502
[TBL] [Abstract][Full Text] [Related]
16. Interferon-stimulated gene expression in black and white hepatitis C patients during peginterferon alfa-2a combination therapy.
Luo S; Cassidy W; Jeffers L; Reddy KR; Bruno C; Howell CD
Clin Gastroenterol Hepatol; 2005 May; 3(5):499-506. PubMed ID: 15880320
[TBL] [Abstract][Full Text] [Related]
17. Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1.
Conjeevaram HS; Fried MW; Jeffers LJ; Terrault NA; Wiley-Lucas TE; Afdhal N; Brown RS; Belle SH; Hoofnagle JH; Kleiner DE; Howell CD;
Gastroenterology; 2006 Aug; 131(2):470-7. PubMed ID: 16890601
[TBL] [Abstract][Full Text] [Related]
18. A comparative analysis of interferons and direct-acting antivirals on the expression of genes involved in hepatitis C pathogenesis.
Farooq M; Rauf M; Tahir F; Manzoor S
J Med Virol; 2021 Nov; 93(11):6241-6246. PubMed ID: 32706418
[TBL] [Abstract][Full Text] [Related]
19. Serial quantitation of serum core protein and viral RNA of hepatitis C virus after interferon therapy: increase in viral loads in biochemical responders.
Yoshioka K; Aiyama T; Iwata K; Yano M; Okumura A; Ishikawa T; Kakumu S
Am J Gastroenterol; 1997 Aug; 92(8):1305-9. PubMed ID: 9260795
[TBL] [Abstract][Full Text] [Related]
20. Analysis of sequence configurations of the ISDR, PKR-binding domain, and V3 region as predictors of response to induction interferon-alpha and ribavirin therapy in chronic hepatitis C infection.
Murphy MD; Rosen HR; Marousek GI; Chou S
Dig Dis Sci; 2002 Jun; 47(6):1195-205. PubMed ID: 12064791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]